Core Viewpoint - Cameco's recent fourth-quarter and 2024 results showed strong revenue growth, but the stock has declined due to concerns over annual earnings and specific operational challenges [1][2][32]. Financial Performance - Fourth-quarter revenues increased by 36.5% year over year to 753 million [8]. - Earnings per share (EPS) for the fourth quarter were 26 cents (CAD 0.36), beating the consensus estimate of 23 cents [8]. - For 2024, revenues rose 21% year over year to 2.15 billion [11]. - Adjusted EPS for 2024 was 47 cents (CAD 0.67), down 24% year over year but above the consensus estimate of 42 cents [12]. Production and Sales - In Q4, Cameco produced 6.1 million pounds of uranium, a 7% increase from the previous year, and sold 12.8 million pounds, a 30% increase [9]. - The average realized uranium price rose 12% year over year to 600 million (1.3 billion ($0.91 billion) in long-term debt, indicating a solid balance sheet for future investments [20]. Market Position and Outlook - Cameco's return on equity stands at 5.6%, significantly higher than the industry average of 1.7% [25]. - The stock is trading at a forward price-to-sales ratio of 7.71, above the industry average of 1.00, suggesting a premium valuation [26]. - The global focus on nuclear energy due to geopolitical events and climate concerns positions Cameco favorably to capitalize on rising low-carbon energy demand [28].
Cameco Stock Dips 7% Despite Posting Q4 Earning Beat: How to Play It?